Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 4
2011 1
2012 13
2013 18
2014 28
2015 15
2016 19
2017 8
2018 3
2019 4
2020 2
2021 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

99 results

Results by year

Filters applied: . Clear all
Page 1
Severe COVID-19 Is Characterized by an Impaired Type I Interferon Response and Elevated Levels of Arginase Producing Granulocytic Myeloid Derived Suppressor Cells.
Dean MJ, Ochoa JB, Sanchez-Pino MD, Zabaleta J, Garai J, Del Valle L, Wyczechowska D, Baiamonte LB, Philbrook P, Majumder R, Vander Heide RS, Dunkenberger L, Thylur RP, Nossaman B, Roberts WM, Chapple AG, Wu J, Hicks C, Collins J, Luke B, Johnson R, Koul HK, Rees CA, Morris CR, Garcia-Diaz J, Ochoa AC. Dean MJ, et al. Front Immunol. 2021 Jul 14;12:695972. doi: 10.3389/fimmu.2021.695972. eCollection 2021. Front Immunol. 2021. PMID: 34341659 Free PMC article.
Circulating Antibodies against Epstein-Barr Virus (EBV) and p53 in EBV-Positive and -Negative Gastric Cancer.
Camargo MC, Kim KM, Matsuo K, Torres J, Liao LM, Morgan D, Michel A, Waterboer T, Song M, Gulley ML, Dominguez RL, Yatabe Y, Kim S, Cortes-Martinez G, Lissowska J, Zabaleta J, Pawlita M, Rabkin CS. Camargo MC, et al. Cancer Epidemiol Biomarkers Prev. 2020 Feb;29(2):414-419. doi: 10.1158/1055-9965.EPI-19-0790. Epub 2019 Nov 12. Cancer Epidemiol Biomarkers Prev. 2020. PMID: 31719065 Free PMC article.
Antibody therapy for Lassa fever.
Cross RW, Hastie KM, Mire CE, Robinson JE, Geisbert TW, Branco LM, Ollmann Saphire E, Garry RF. Cross RW, et al. Curr Opin Virol. 2019 Aug;37:97-104. doi: 10.1016/j.coviro.2019.07.003. Epub 2019 Aug 8. Curr Opin Virol. 2019. PMID: 31401518 Review.
A medical records and data capture and management system for Lassa fever in Sierra Leone: Approach, implementation, and challenges.
Shaffer JG, Schieffelin JS, Gbakie M, Alhasan F, Roberts NB, Goba A, Randazzo J, Momoh M, Moon TD, Kanneh L, Levy DC, Podgorski RM, Hartnett JN, Boisen ML, Branco LM, Samuels R, Grant DS, Garry RF; Viral Hemorrhagic Fever Consortium. Shaffer JG, et al. PLoS One. 2019 Mar 28;14(3):e0214284. doi: 10.1371/journal.pone.0214284. eCollection 2019. PLoS One. 2019. PMID: 30921383 Free PMC article.
99 results